InMed Pharmaceuticals Inc. Common Shares

INMNASDAQ • USD
ThemeBiotech - Drug Development›Rare Disease Therapeutics
1.91 USD
↗ 0.37 (24.16%)🟢LIVE (AS OF 10:56 AM EDT)
🟢Market: OPEN

InMed Pharmaceuticals Inc. Common Shares (INM) is currently trading at $1.91. INM shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Jul 21, 2026.

Open?$2.15
High?$4.79
Low?$1.57
Prev. Close?$1.54
Volume?46.9M
Avg. Volume?40.9K
VWAP?$2.66
Rel. Volume?1,147.42x
Bid / Ask
Bid?$2.06 × 100
Ask?$2.08 × 300
Spread?$0.02
Midpoint?$2.07
Valuation & Ratios
Market Cap?8.2M
Shares Out?3.3M
Float?2.6M
Float %?89.2%
P/E Ratio?N/A
P/B Ratio?1.19
EPS?-$1.59
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.
Themes
Biotech - Drug Development›Rare Disease TherapeuticsCannabis›CBD & Hemp Products
Employees
13
Market Cap
8.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.inmedpharma.com
Listed
2020-11-10
Address
1445-885 WEST GEORGIA ST.
VANCOUVER, A1 V6C 3E8
Phone: (604) 669-7207
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
7
Short Sent.?
69
Piotroski F-Score?0/9Weak
Altman Z-Score?-18.82Distress
Confidence?44%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?5.45%Elevated
Short Interest?141.8K
Days to Cover?4.3
Free Float2.6M
Avg Daily Volume33.0K
Settlement Date2026-06-30
Financial Health
Current Ratio?4.92Strong
Quick Ratio?4.92Strong
Cash Ratio?3.68Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
93
1.19CHEAP▾
P/S?
Peers
100
S&P
57
2.53CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.4CHEAP▾
EV/Sales?
Peers
100
S&P
92
0.94CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-123.5%WEAK▾
ROA?
S&P
3
-93.2%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$3.1M
Fundamentals ratios updated end of day
MarketsMoversWatchlist